- A former director of clinical operations was matched to a pioneering combination product company working on trauma patients to drive their pivotal trials forward.
- A translational pharmacologist and leading scientist in the immuno-oncology arena was matched to a small biotech company focused on novel T-Cell based treatments to initiate collaborations to source tumor tissue.
- A former BMS program manager was matched to a publicly traded rare disease company to drive development plans forward across regulatory, CMC, and clinical activities.
- A seasoned former Gilead biostatistician with over three decades of IND-enabling experience was matched with an early-stage biotech company focused on preclinical development for neurological indications.
- A seasoned R&D Executive and one of Clora’s top-tier consultants in clinical development was matched as an interim CMO with a biotech company focused on predictive medicine for hematological indications.
- A senior IT professional with experience in the management of IT implementation/compliance in Pharma R&D matched to a gene therapy company to implement Laboratory Information Management Systems (LIMS).